Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of PolyPEPI1018 Vaccine in Combination With Atezolizumab in Participants With Relapsed or Refractory Microsatellite-stable Metastatic Colorectal Cancer.

NCT05243862 is registered in ClinicalTrials.gov with Treos Bio Limited as lead sponsor.

NCT NCT05243862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05243862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of PolyPEPI1018 Vaccine in Combination With Atezolizumab in Participants With Relapsed or Refractory Microsatellite-stable Metastatic Colorectal Cancer.
Lead sponsor
Treos Bio Limited
Phase
Phase 2
Overall status
Completed
Start date
June 2, 2022
Completion date
January 14, 2025
Enrollment
18 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic